AB Science reports fourth consecutive case of response from Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid ...

PRESS RELEASEAB SCIENCE REPORTS FOURTH CONSECUTIVE CASE OF RESPONSE FROM PHASE 1 DATA FOR THE COMBINATION OF AB8939 WITH VENETOCLAX FOR THE ...

Syndax and World Orphan Drug Alliance to Launch a Multi-Regional Managed Access Program, Expanding Access to Revuforj® (revumenib) Outside the U.S.

Syndax Pharmaceuticals (Nasdaq: SNDX) and the World Orphan Drug Alliance (WODA) today announced a collaboration to expand access to the Company’s first-in-class menin inhibitor, Revuforj ® (revumenib) ...

Prime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference

Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time ...

Top 50 CBSE class 12 chemistry MCQs with answers for high score in pre board exam 2026

CBSE Class 12 Chemistry is a crucial subject that requires strong conceptual clarity and regular practice to score well in ...
Opinion
New StatesmanOpinion

Venezuela and the mutation of American imperialism

The US framed its 1989 Panama invasion as a targeted capture of a rogue head of state wanted for drug trafficking ...
PharmiWeb

Daiichi Sankyo and GENESIS Pharma Enter Exclusive Agreement for VANFLYTA® Commercialization in Central and Eastern Europe

Exclusive agreement covers 13 Central and Eastern European marketsCollaboration will help expand access to VANFLYTA for ...

THE CHOKE POINT: 5 Assets That Control the Bottleneck

Issued on behalf of GoldHaven Resources Corp. VANCOUVER, British Columbia, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Equity InsiderMarket Intelligence ...